Waters Corporation
WAT Healthcare Diagnostics & Research
Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024.
- Revenue
- +120.9%
- EPS
- −67.0%
- Free cash flow
- −66.7%
- Total debt
- +308.2%
Quarter to September 2026, against a year earlier
Follow WAT
Alert me
Waters Corporation (WAT) P/S ratio
As of 5 November 2026, Waters Corporation (WAT) trades at a P/S ratio of 8.0×. Over the past ten years it has ranged from 4.6× (March 2020) to 9.8× (September 2021); the current reading is higher than 93% of that period. That is above the Diagnostics & Research industry median of 4.2× and above the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 7.1× | (4.02%) |
| FY2024 | 7.4× | 13.31% |
| FY2023 | 6.6× | (5.86%) |
| FY2022 | 7.0× | (15.30%) |
| FY2021 | 8.2× | 26.79% |
| FY2020 | 6.5× | (1.08%) |
| FY2019 | 6.6× | 9.39% |
| FY2018 | 6.0× | (11.24%) |
| FY2017 | 6.8× | 32.98% |
| FY2016 | 5.1× | (6.28%) |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 7.7× | (2.98%) |
| Jun 2026 | 7.9× | 22.23% |
| Mar 2026 | 6.5× | (9.15%) |
| Dec 2025 | 7.1× | 24.26% |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| LH Labcorp Holdings Inc. compare | 2.0× |
| DGX Quest Diagnostics Incorporated compare | 2.4× |
| IQV IQVIA Holdings Inc. compare | 2.5× |
| A Agilent Technologies, Inc. compare | 6.6× |
| ILMN Illumina, Inc. compare | 7.0× |
| WAT Waters Corporation | 8.0× |
| MTD Mettler-Toledo International, Inc. compare | 8.2× |
| IDXX IDEXX Laboratories, Inc. compare | 11.3× |
| NTRA Natera, Inc. compare | 18.1× |
| Diagnostics & Research industry median | 4.2× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on WAT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement